John Kappler
Concepts (909)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 234 | 2021 | 1737 | 6.970 |
Why?
| Receptors, Antigen, T-Cell | 121 | 2021 | 615 | 6.070 |
Why?
| Histocompatibility Antigens Class II | 78 | 2021 | 352 | 5.690 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 62 | 2019 | 309 | 5.350 |
Why?
| CD4-Positive T-Lymphocytes | 52 | 2021 | 959 | 4.310 |
Why?
| Major Histocompatibility Complex | 55 | 2021 | 217 | 3.840 |
Why?
| Peptides | 46 | 2021 | 848 | 2.730 |
Why?
| Peptide Fragments | 24 | 2021 | 666 | 2.700 |
Why?
| Thymus Gland | 56 | 2021 | 296 | 2.580 |
Why?
| Hybridomas | 74 | 2019 | 230 | 2.530 |
Why?
| Lymphocyte Activation | 78 | 2020 | 1037 | 2.240 |
Why?
| Mice | 322 | 2021 | 14872 | 2.070 |
Why?
| Antigens | 48 | 2021 | 318 | 2.070 |
Why?
| Histocompatibility Antigens | 17 | 2019 | 98 | 1.930 |
Why?
| Epitopes, T-Lymphocyte | 9 | 2021 | 170 | 1.820 |
Why?
| Animals | 360 | 2021 | 31709 | 1.730 |
Why?
| B-Lymphocytes | 61 | 2017 | 766 | 1.730 |
Why?
| H-2 Antigens | 38 | 2011 | 110 | 1.670 |
Why?
| Autoantigens | 22 | 2021 | 396 | 1.510 |
Why?
| Amino Acid Sequence | 71 | 2019 | 1982 | 1.480 |
Why?
| Autoimmunity | 13 | 2021 | 813 | 1.460 |
Why?
| Epitopes | 47 | 2021 | 435 | 1.440 |
Why?
| Berylliosis | 10 | 2021 | 177 | 1.380 |
Why?
| Protein Binding | 36 | 2021 | 1890 | 1.300 |
Why?
| Autoimmune Diseases | 6 | 2021 | 382 | 1.240 |
Why?
| Molecular Sequence Data | 67 | 2015 | 2785 | 1.210 |
Why?
| Enterotoxins | 26 | 2009 | 88 | 1.200 |
Why?
| Models, Molecular | 27 | 2018 | 1369 | 1.190 |
Why?
| Immune Tolerance | 30 | 2021 | 323 | 1.160 |
Why?
| Diabetes Mellitus, Type 1 | 16 | 2021 | 3256 | 1.130 |
Why?
| Histocompatibility Antigens Class I | 12 | 2018 | 172 | 1.110 |
Why?
| Antibodies, Monoclonal | 54 | 2020 | 1264 | 1.070 |
Why?
| Immunologic Memory | 25 | 2020 | 313 | 1.050 |
Why?
| Beryllium | 8 | 2021 | 146 | 1.040 |
Why?
| Antigen Presentation | 15 | 2021 | 188 | 1.000 |
Why?
| Baculoviridae | 9 | 2015 | 44 | 0.990 |
Why?
| Alleles | 13 | 2017 | 789 | 0.990 |
Why?
| HLA-DP beta-Chains | 10 | 2021 | 76 | 0.970 |
Why?
| CD8-Positive T-Lymphocytes | 21 | 2021 | 688 | 0.930 |
Why?
| Insulin | 10 | 2020 | 2080 | 0.910 |
Why?
| Interleukin-2 | 37 | 2015 | 413 | 0.890 |
Why?
| Superantigens | 18 | 2002 | 69 | 0.850 |
Why?
| Mice, Inbred C57BL | 97 | 2020 | 4694 | 0.820 |
Why?
| Antigens, Surface | 24 | 2011 | 146 | 0.800 |
Why?
| Cell Line | 41 | 2021 | 2637 | 0.750 |
Why?
| Lysosomes | 2 | 2021 | 123 | 0.740 |
Why?
| Cathepsins | 1 | 2021 | 22 | 0.740 |
Why?
| Antigens, Neoplasm | 7 | 2021 | 222 | 0.720 |
Why?
| HLA-DR Antigens | 9 | 2016 | 219 | 0.720 |
Why?
| T-Lymphocyte Subsets | 19 | 2013 | 383 | 0.700 |
Why?
| Mice, Transgenic | 45 | 2021 | 1950 | 0.700 |
Why?
| Peptide Library | 6 | 2013 | 81 | 0.700 |
Why?
| Protein Conformation | 20 | 2018 | 805 | 0.700 |
Why?
| Adjuvants, Immunologic | 12 | 2016 | 206 | 0.690 |
Why?
| Flow Cytometry | 28 | 2015 | 1083 | 0.680 |
Why?
| Islets of Langerhans | 4 | 2021 | 728 | 0.660 |
Why?
| Immunoglobulin G | 10 | 2017 | 770 | 0.640 |
Why?
| Genes, MHC Class II | 18 | 2014 | 69 | 0.620 |
Why?
| Base Sequence | 36 | 2016 | 2114 | 0.610 |
Why?
| Mammary Tumor Virus, Mouse | 12 | 1995 | 42 | 0.600 |
Why?
| Chromogranin A | 2 | 2015 | 39 | 0.580 |
Why?
| Membrane Proteins | 14 | 2020 | 1019 | 0.580 |
Why?
| Amino Acids | 5 | 2022 | 448 | 0.570 |
Why?
| Binding Sites | 20 | 2021 | 1168 | 0.570 |
Why?
| Mice, Inbred BALB C | 48 | 2021 | 1144 | 0.560 |
Why?
| Mice, Inbred NOD | 11 | 2020 | 555 | 0.540 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 25 | 0.540 |
Why?
| Ikaros Transcription Factor | 2 | 2013 | 18 | 0.520 |
Why?
| Lymphocyte Cooperation | 21 | 1990 | 49 | 0.510 |
Why?
| Complementarity Determining Regions | 8 | 2012 | 43 | 0.510 |
Why?
| Proto-Oncogene Proteins | 12 | 2009 | 608 | 0.500 |
Why?
| Antigen-Presenting Cells | 20 | 2015 | 150 | 0.500 |
Why?
| Immunity, Cellular | 16 | 2010 | 248 | 0.500 |
Why?
| CD3 Complex | 10 | 2018 | 92 | 0.500 |
Why?
| Alum Compounds | 6 | 2016 | 22 | 0.490 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 82 | 0.490 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 11 | 2007 | 213 | 0.480 |
Why?
| Evolution, Molecular | 4 | 2019 | 430 | 0.480 |
Why?
| Hypersensitivity | 3 | 2016 | 252 | 0.470 |
Why?
| Mutation | 25 | 2022 | 3346 | 0.470 |
Why?
| Histone Demethylases | 3 | 2020 | 28 | 0.470 |
Why?
| Gene Expression Regulation | 22 | 2015 | 2320 | 0.460 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 18 | 1991 | 84 | 0.460 |
Why?
| bcl-2-Associated X Protein | 4 | 2006 | 45 | 0.460 |
Why?
| Immunoglobulin Variable Region | 11 | 2012 | 72 | 0.450 |
Why?
| Thymoma | 5 | 2012 | 30 | 0.450 |
Why?
| Antibody Formation | 21 | 2010 | 266 | 0.440 |
Why?
| Mice, Inbred Strains | 36 | 2000 | 396 | 0.440 |
Why?
| Spleen | 32 | 2016 | 487 | 0.430 |
Why?
| Conserved Sequence | 3 | 2009 | 218 | 0.430 |
Why?
| Lymphocytes, Null | 1 | 2012 | 2 | 0.420 |
Why?
| Lymphokines | 12 | 1984 | 111 | 0.420 |
Why?
| HLA-DR4 Antigen | 2 | 2005 | 76 | 0.420 |
Why?
| Protein Processing, Post-Translational | 8 | 2018 | 399 | 0.420 |
Why?
| Bacterial Toxins | 6 | 1997 | 103 | 0.420 |
Why?
| Humans | 127 | 2022 | 114709 | 0.410 |
Why?
| Antigens, Viral | 10 | 2001 | 176 | 0.410 |
Why?
| Staphylococcus aureus | 12 | 1999 | 389 | 0.410 |
Why?
| Crystallography, X-Ray | 9 | 2018 | 402 | 0.400 |
Why?
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 92 | 0.400 |
Why?
| Apoptosis | 14 | 2011 | 2363 | 0.400 |
Why?
| Apoptosis Regulatory Proteins | 10 | 2011 | 171 | 0.400 |
Why?
| Ligands | 12 | 2022 | 562 | 0.390 |
Why?
| Glycoproteins | 3 | 2011 | 304 | 0.390 |
Why?
| Cancer Vaccines | 5 | 2021 | 137 | 0.380 |
Why?
| Antigens, Bacterial | 8 | 2013 | 112 | 0.370 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 3 | 2018 | 59 | 0.360 |
Why?
| Toll-Like Receptor 7 | 4 | 2016 | 35 | 0.360 |
Why?
| Carrier Proteins | 10 | 2009 | 695 | 0.360 |
Why?
| Interferon-gamma | 14 | 2016 | 719 | 0.350 |
Why?
| Protein Structure, Tertiary | 9 | 2021 | 796 | 0.350 |
Why?
| Cells, Cultured | 35 | 2021 | 3886 | 0.350 |
Why?
| Antibodies | 10 | 2009 | 371 | 0.350 |
Why?
| B-Lymphocyte Subsets | 4 | 2020 | 68 | 0.350 |
Why?
| Cell Differentiation | 28 | 2021 | 1701 | 0.350 |
Why?
| Signal Transduction | 17 | 2016 | 4516 | 0.330 |
Why?
| Immunotherapy | 5 | 2021 | 474 | 0.330 |
Why?
| Proinsulin | 2 | 2021 | 48 | 0.320 |
Why?
| Clone Cells | 21 | 2014 | 247 | 0.310 |
Why?
| Nickel | 2 | 2012 | 50 | 0.310 |
Why?
| CD11c Antigen | 5 | 2020 | 38 | 0.300 |
Why?
| Ovalbumin | 20 | 2011 | 161 | 0.300 |
Why?
| Cytokines | 13 | 2020 | 1841 | 0.300 |
Why?
| Arthritis, Rheumatoid | 5 | 2014 | 1003 | 0.290 |
Why?
| HLA-DQ Antigens | 6 | 2019 | 174 | 0.290 |
Why?
| Gene Expression | 10 | 2017 | 1421 | 0.290 |
Why?
| Immunoglobulin Fab Fragments | 3 | 2006 | 69 | 0.280 |
Why?
| Cross Reactions | 9 | 2012 | 117 | 0.280 |
Why?
| beta 2-Microglobulin | 4 | 2010 | 45 | 0.280 |
Why?
| Histones | 4 | 2018 | 535 | 0.270 |
Why?
| Insecta | 4 | 2009 | 64 | 0.270 |
Why?
| Dendritic Cells | 7 | 2013 | 435 | 0.270 |
Why?
| Cell Proliferation | 10 | 2020 | 2187 | 0.270 |
Why?
| Lupus Erythematosus, Systemic | 3 | 2017 | 219 | 0.250 |
Why?
| HLA-D Antigens | 3 | 1998 | 34 | 0.250 |
Why?
| Kinetics | 17 | 2021 | 1551 | 0.250 |
Why?
| Transcription, Genetic | 8 | 2020 | 1313 | 0.250 |
Why?
| Amino Acid Motifs | 6 | 2019 | 197 | 0.250 |
Why?
| Staphylococcus | 5 | 1994 | 69 | 0.240 |
Why?
| Cell Survival | 17 | 2009 | 1021 | 0.240 |
Why?
| Interleukin-12 | 2 | 2016 | 110 | 0.230 |
Why?
| Protein Folding | 2 | 2021 | 239 | 0.230 |
Why?
| Herpesviridae Infections | 2 | 2017 | 138 | 0.230 |
Why?
| Macrophages | 18 | 2011 | 1263 | 0.220 |
Why?
| T-Lymphocytes, Helper-Inducer | 9 | 1989 | 127 | 0.220 |
Why?
| Neoplasms | 5 | 2021 | 2097 | 0.220 |
Why?
| Macromolecular Substances | 17 | 2003 | 200 | 0.220 |
Why?
| Lung | 7 | 2021 | 3561 | 0.220 |
Why?
| Positive Transcriptional Elongation Factor B | 2 | 2020 | 22 | 0.220 |
Why?
| Surface Plasmon Resonance | 5 | 2021 | 81 | 0.220 |
Why?
| Antiviral Agents | 2 | 2021 | 645 | 0.220 |
Why?
| DNA | 12 | 2016 | 1352 | 0.220 |
Why?
| T-Cell Antigen Receptor Specificity | 3 | 2011 | 41 | 0.210 |
Why?
| Germ Cells | 2 | 2016 | 57 | 0.210 |
Why?
| Receptors, Cell Surface | 3 | 2020 | 355 | 0.210 |
Why?
| Concanavalin A | 18 | 1990 | 74 | 0.210 |
Why?
| T-Box Domain Proteins | 4 | 2020 | 92 | 0.210 |
Why?
| Enzyme-Linked Immunosorbent Assay | 10 | 2017 | 797 | 0.210 |
Why?
| Cell Death | 13 | 2006 | 323 | 0.210 |
Why?
| Antibodies, Monoclonal, Humanized | 3 | 2022 | 663 | 0.200 |
Why?
| Natural Killer T-Cells | 2 | 2013 | 63 | 0.200 |
Why?
| Homeostasis | 5 | 2007 | 573 | 0.200 |
Why?
| Aging | 8 | 2015 | 1618 | 0.200 |
Why?
| Vaccines, Subunit | 3 | 2012 | 41 | 0.200 |
Why?
| Neoplasms, Experimental | 3 | 2021 | 151 | 0.200 |
Why?
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 740 | 0.200 |
Why?
| Immune System | 5 | 2013 | 172 | 0.200 |
Why?
| Transfection | 17 | 2009 | 866 | 0.200 |
Why?
| Female | 70 | 2021 | 59523 | 0.200 |
Why?
| Recombinant Proteins | 7 | 2005 | 1230 | 0.200 |
Why?
| Saccharomyces cerevisiae | 1 | 2005 | 476 | 0.200 |
Why?
| Polymorphism, Genetic | 6 | 2012 | 610 | 0.190 |
Why?
| Sequence Homology, Amino Acid | 6 | 2019 | 353 | 0.190 |
Why?
| Pancreas | 2 | 2021 | 276 | 0.190 |
Why?
| Peptidyl Transferases | 1 | 2021 | 7 | 0.190 |
Why?
| Crystallization | 2 | 2015 | 136 | 0.190 |
Why?
| Mice, Knockout | 16 | 2017 | 2570 | 0.190 |
Why?
| Chemokine CCL3 | 1 | 2021 | 15 | 0.190 |
Why?
| Chemokine CCL4 | 1 | 2021 | 21 | 0.190 |
Why?
| Bcl-2-Like Protein 11 | 9 | 2009 | 37 | 0.190 |
Why?
| Structure-Activity Relationship | 9 | 2006 | 502 | 0.180 |
Why?
| Autoantibodies | 6 | 2017 | 1349 | 0.180 |
Why?
| HLA-C Antigens | 1 | 2021 | 33 | 0.180 |
Why?
| Inflammation | 5 | 2020 | 2480 | 0.180 |
Why?
| Electrophoresis, Polyacrylamide Gel | 9 | 2011 | 318 | 0.180 |
Why?
| RNA Polymerase II | 2 | 2020 | 284 | 0.180 |
Why?
| Cloning, Molecular | 12 | 2000 | 522 | 0.180 |
Why?
| Epitope Mapping | 4 | 2015 | 51 | 0.180 |
Why?
| Immunoglobulin Idiotypes | 6 | 1986 | 19 | 0.180 |
Why?
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 9 | 0.180 |
Why?
| Synovial Fluid | 2 | 2000 | 56 | 0.180 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 590 | 0.170 |
Why?
| HLA-DP Antigens | 2 | 2010 | 32 | 0.170 |
Why?
| Disease Models, Animal | 7 | 2015 | 3535 | 0.170 |
Why?
| Membrane Glycoproteins | 6 | 2013 | 430 | 0.170 |
Why?
| Sarcoidosis, Pulmonary | 1 | 2020 | 58 | 0.170 |
Why?
| Substrate Specificity | 3 | 2017 | 352 | 0.170 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 228 | 0.170 |
Why?
| Nerve Growth Factors | 1 | 2000 | 71 | 0.170 |
Why?
| Hemolytic Plaque Technique | 16 | 1983 | 29 | 0.170 |
Why?
| Haptens | 4 | 1988 | 21 | 0.170 |
Why?
| Animal Fur | 1 | 2019 | 1 | 0.170 |
Why?
| Glycosaminoglycans | 1 | 2000 | 79 | 0.170 |
Why?
| Genes | 15 | 1990 | 223 | 0.170 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2020 | 86 | 0.170 |
Why?
| CD8 Antigens | 9 | 2006 | 69 | 0.170 |
Why?
| Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.170 |
Why?
| Cell Separation | 13 | 2014 | 291 | 0.170 |
Why?
| Lipocalins | 1 | 2019 | 34 | 0.170 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 372 | 0.160 |
Why?
| Methyltransferases | 1 | 2020 | 61 | 0.160 |
Why?
| Vaccines | 3 | 2016 | 375 | 0.160 |
Why?
| Cell Line, Transformed | 2 | 2018 | 133 | 0.160 |
Why?
| Induced Pluripotent Stem Cells | 1 | 2021 | 182 | 0.160 |
Why?
| T-Lymphocytes, Regulatory | 4 | 2014 | 339 | 0.160 |
Why?
| Cell Line, Tumor | 6 | 2021 | 2711 | 0.160 |
Why?
| Interleukin-4 | 6 | 2008 | 206 | 0.160 |
Why?
| Protein Structure, Secondary | 5 | 2012 | 325 | 0.160 |
Why?
| HIV Envelope Protein gp120 | 1 | 1999 | 56 | 0.160 |
Why?
| Molecular Weight | 12 | 2006 | 331 | 0.160 |
Why?
| Gene Expression Profiling | 5 | 2013 | 1518 | 0.150 |
Why?
| Mice, Mutant Strains | 8 | 2014 | 271 | 0.150 |
Why?
| Antibody Specificity | 11 | 2020 | 176 | 0.150 |
Why?
| Lymph Nodes | 11 | 2013 | 419 | 0.150 |
Why?
| Th2 Cells | 3 | 2010 | 154 | 0.150 |
Why?
| Genome | 2 | 2000 | 271 | 0.150 |
Why?
| Mice, Inbred DBA | 19 | 2001 | 174 | 0.150 |
Why?
| Antigens, Ly | 4 | 1988 | 45 | 0.150 |
Why?
| Hybrid Cells | 4 | 1997 | 49 | 0.150 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 97 | 0.150 |
Why?
| bcl-X Protein | 4 | 2006 | 38 | 0.150 |
Why?
| Hemocyanins | 9 | 1983 | 55 | 0.150 |
Why?
| Vaccination | 7 | 2010 | 1204 | 0.150 |
Why?
| Cell Division | 11 | 2008 | 758 | 0.140 |
Why?
| Interleukin-7 | 4 | 2004 | 45 | 0.140 |
Why?
| Herpesviridae | 1 | 2017 | 21 | 0.140 |
Why?
| Cat Diseases | 1 | 2017 | 13 | 0.140 |
Why?
| Species Specificity | 11 | 2006 | 542 | 0.140 |
Why?
| Erythrocytes | 24 | 1983 | 591 | 0.140 |
Why?
| Cell Communication | 8 | 2013 | 280 | 0.140 |
Why?
| Spodoptera | 3 | 2021 | 36 | 0.140 |
Why?
| Fluorescent Antibody Technique | 6 | 2011 | 397 | 0.140 |
Why?
| Solubility | 5 | 2003 | 223 | 0.140 |
Why?
| Germ-Line Mutation | 2 | 2009 | 130 | 0.130 |
Why?
| Ubiquitin-Protein Ligases | 2 | 2008 | 139 | 0.130 |
Why?
| Friend murine leukemia virus | 1 | 2016 | 30 | 0.130 |
Why?
| Deoxyribonucleases | 1 | 2016 | 21 | 0.130 |
Why?
| Antibody-Producing Cells | 11 | 1983 | 29 | 0.130 |
Why?
| Antibody Affinity | 4 | 2020 | 52 | 0.130 |
Why?
| Genetic Predisposition to Disease | 6 | 2021 | 2087 | 0.130 |
Why?
| Immunity | 3 | 2007 | 121 | 0.130 |
Why?
| Thymocytes | 2 | 2013 | 28 | 0.130 |
Why?
| Mice, Inbred AKR | 10 | 1989 | 34 | 0.130 |
Why?
| Immunologic Deficiency Syndromes | 3 | 2007 | 61 | 0.130 |
Why?
| Protein Precursors | 1 | 2016 | 119 | 0.130 |
Why?
| Mast Cells | 2 | 2009 | 116 | 0.130 |
Why?
| Allergens | 1 | 2019 | 413 | 0.130 |
Why?
| Clonal Anergy | 3 | 2006 | 53 | 0.130 |
Why?
| Binding, Competitive | 9 | 2010 | 193 | 0.130 |
Why?
| Hematopoietic Stem Cells | 3 | 1988 | 343 | 0.130 |
Why?
| Breast Neoplasms | 2 | 2018 | 1862 | 0.130 |
Why?
| Methylation | 5 | 2018 | 208 | 0.130 |
Why?
| Reactive Oxygen Species | 3 | 2003 | 531 | 0.120 |
Why?
| History, 20th Century | 4 | 2016 | 264 | 0.120 |
Why?
| Cytotoxicity, Immunologic | 8 | 2010 | 195 | 0.120 |
Why?
| Influenza A virus | 2 | 2013 | 90 | 0.120 |
Why?
| Transcription Factors | 4 | 2012 | 1528 | 0.120 |
Why?
| Polymerase Chain Reaction | 7 | 2016 | 993 | 0.120 |
Why?
| Cerebroside-Sulfatase | 2 | 1993 | 3 | 0.120 |
Why?
| Leukodystrophy, Metachromatic | 2 | 1993 | 3 | 0.120 |
Why?
| T-Lymphocytes, Cytotoxic | 4 | 2011 | 154 | 0.120 |
Why?
| RNA, Messenger | 10 | 2022 | 2553 | 0.120 |
Why?
| Interleukin-15 | 5 | 2006 | 74 | 0.120 |
Why?
| Self Tolerance | 2 | 1996 | 28 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 6 | 2006 | 1140 | 0.120 |
Why?
| Peptide Biosynthesis | 1 | 1994 | 13 | 0.120 |
Why?
| Receptors, Immunologic | 3 | 2020 | 201 | 0.120 |
Why?
| Cysteine | 2 | 2010 | 171 | 0.120 |
Why?
| Ribosomal Proteins | 1 | 2014 | 70 | 0.120 |
Why?
| Mutagenesis, Site-Directed | 3 | 2011 | 345 | 0.120 |
Why?
| Mutagenesis | 3 | 2021 | 168 | 0.110 |
Why?
| Antigens, CD | 5 | 2001 | 442 | 0.110 |
Why?
| Immunity, Innate | 4 | 2021 | 720 | 0.110 |
Why?
| Granuloma | 1 | 2014 | 83 | 0.110 |
Why?
| Haplotypes | 4 | 1990 | 448 | 0.110 |
Why?
| Viral Proteins | 2 | 2009 | 281 | 0.110 |
Why?
| gamma-Globulins | 4 | 1983 | 18 | 0.110 |
Why?
| Diabetes Mellitus | 1 | 2021 | 900 | 0.110 |
Why?
| Sodium | 1 | 2014 | 183 | 0.110 |
Why?
| Clonal Deletion | 4 | 2004 | 16 | 0.110 |
Why?
| Hydrogen Bonding | 2 | 2008 | 143 | 0.110 |
Why?
| Genetic Linkage | 7 | 1989 | 294 | 0.110 |
Why?
| Nucleoproteins | 1 | 2013 | 27 | 0.110 |
Why?
| Escherichia coli | 4 | 2013 | 720 | 0.110 |
Why?
| Gammaherpesvirinae | 1 | 2013 | 38 | 0.110 |
Why?
| HLA Antigens | 4 | 2018 | 225 | 0.110 |
Why?
| Chimera | 8 | 2009 | 59 | 0.110 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 66 | 0.100 |
Why?
| Antigen-Antibody Reactions | 7 | 2021 | 50 | 0.100 |
Why?
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 24 | 0.100 |
Why?
| CD4 Antigens | 9 | 1998 | 123 | 0.100 |
Why?
| Genes, Immunoglobulin | 3 | 1988 | 26 | 0.100 |
Why?
| Multiprotein Complexes | 1 | 2014 | 140 | 0.100 |
Why?
| Models, Immunological | 4 | 2008 | 92 | 0.100 |
Why?
| Intestinal Mucosa | 1 | 1997 | 532 | 0.100 |
Why?
| B7-1 Antigen | 3 | 2004 | 53 | 0.100 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 100 | 0.100 |
Why?
| Communicable Diseases | 1 | 1994 | 129 | 0.100 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 33 | 0.100 |
Why?
| Dermatitis, Allergic Contact | 1 | 2012 | 63 | 0.100 |
Why?
| Dose-Response Relationship, Immunologic | 12 | 2000 | 75 | 0.100 |
Why?
| Sheep | 20 | 1983 | 764 | 0.090 |
Why?
| Male | 29 | 2021 | 55609 | 0.090 |
Why?
| Receptors, CXCR5 | 1 | 2011 | 11 | 0.090 |
Why?
| Antilymphocyte Serum | 9 | 1981 | 60 | 0.090 |
Why?
| Glycosylation | 4 | 1994 | 130 | 0.090 |
Why?
| Lipid A | 1 | 2011 | 28 | 0.090 |
Why?
| Lymphocyte Depletion | 4 | 1992 | 116 | 0.090 |
Why?
| Molecular Conformation | 2 | 2009 | 135 | 0.090 |
Why?
| Th1 Cells | 2 | 2010 | 123 | 0.090 |
Why?
| Insulin-Secreting Cells | 2 | 2016 | 317 | 0.090 |
Why?
| DNA-Binding Proteins | 3 | 2014 | 1314 | 0.090 |
Why?
| Trypsin | 5 | 2006 | 66 | 0.090 |
Why?
| Aluminum | 1 | 2010 | 34 | 0.090 |
Why?
| Neoplasm Proteins | 1 | 2013 | 385 | 0.090 |
Why?
| Lymphocyte Count | 4 | 2010 | 133 | 0.090 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.090 |
Why?
| DNA, Recombinant | 4 | 2005 | 41 | 0.090 |
Why?
| Gene Deletion | 2 | 2009 | 356 | 0.090 |
Why?
| Complement C3 | 1 | 2011 | 188 | 0.090 |
Why?
| Immunization | 8 | 2004 | 397 | 0.090 |
Why?
| Epstein-Barr Virus Nuclear Antigens | 1 | 2009 | 8 | 0.090 |
Why?
| Chronic Disease | 5 | 2021 | 1578 | 0.090 |
Why?
| Chickens | 9 | 1994 | 177 | 0.090 |
Why?
| Time Factors | 12 | 2013 | 6116 | 0.090 |
Why?
| Antibodies, Neutralizing | 2 | 2022 | 222 | 0.080 |
Why?
| RNA | 4 | 2010 | 809 | 0.080 |
Why?
| Molecular Mimicry | 1 | 2009 | 35 | 0.080 |
Why?
| Chromosomes, Human, X | 1 | 2010 | 60 | 0.080 |
Why?
| In Vitro Techniques | 8 | 2000 | 1016 | 0.080 |
Why?
| Radiation Chimera | 6 | 2001 | 30 | 0.080 |
Why?
| Leukemia, Lymphoid | 3 | 2006 | 27 | 0.080 |
Why?
| Molecular Docking Simulation | 2 | 2021 | 101 | 0.080 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 13 | 0.080 |
Why?
| Histidine | 2 | 2003 | 57 | 0.080 |
Why?
| HLA-B Antigens | 1 | 2009 | 56 | 0.080 |
Why?
| Immunoglobulin Heavy Chains | 6 | 1988 | 72 | 0.080 |
Why?
| Cell Membrane | 6 | 2004 | 680 | 0.080 |
Why?
| Phagocytosis | 1 | 2011 | 350 | 0.080 |
Why?
| Macrophages, Peritoneal | 1 | 2009 | 93 | 0.080 |
Why?
| Mice, Inbred C3H | 7 | 1993 | 239 | 0.080 |
Why?
| Immunity, Humoral | 2 | 2022 | 112 | 0.080 |
Why?
| Homeodomain Proteins | 1 | 2012 | 463 | 0.080 |
Why?
| Hydrogen-Ion Concentration | 3 | 2003 | 511 | 0.080 |
Why?
| Sequence Alignment | 2 | 2008 | 323 | 0.080 |
Why?
| Oligopeptides | 2 | 2001 | 236 | 0.080 |
Why?
| Receptors, Interleukin-2 | 4 | 2003 | 64 | 0.080 |
Why?
| Fluorescent Dyes | 2 | 2001 | 301 | 0.080 |
Why?
| Lymphocytes | 6 | 1997 | 330 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2008 | 12 | 0.080 |
Why?
| Chromosome Mapping | 6 | 1989 | 487 | 0.080 |
Why?
| Gonadal Steroid Hormones | 1 | 2010 | 124 | 0.080 |
Why?
| Interleukin-6 | 3 | 2011 | 676 | 0.080 |
Why?
| Mass Spectrometry | 3 | 2020 | 633 | 0.080 |
Why?
| Protein Domains | 2 | 2020 | 207 | 0.080 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 26 | 0.080 |
Why?
| Ubiquitination | 1 | 2008 | 86 | 0.080 |
Why?
| Chondroitin | 1 | 1988 | 5 | 0.080 |
Why?
| Herpesvirus 4, Human | 1 | 2009 | 125 | 0.080 |
Why?
| Cell Movement | 5 | 2013 | 869 | 0.080 |
Why?
| Receptors, Chemokine | 1 | 2008 | 44 | 0.080 |
Why?
| Crosses, Genetic | 6 | 2006 | 139 | 0.070 |
Why?
| Interferon-beta | 2 | 2006 | 79 | 0.070 |
Why?
| Receptors, Tumor Necrosis Factor | 3 | 2003 | 140 | 0.070 |
Why?
| Chondroitin Sulfates | 1 | 1988 | 33 | 0.070 |
Why?
| Phenotype | 10 | 2008 | 2797 | 0.070 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 115 | 0.070 |
Why?
| Galactosylceramides | 1 | 2007 | 22 | 0.070 |
Why?
| Cytochrome c Group | 4 | 1997 | 36 | 0.070 |
Why?
| Oxidoreductases, N-Demethylating | 1 | 2007 | 10 | 0.070 |
Why?
| Antigens, CD1d | 3 | 2013 | 63 | 0.070 |
Why?
| Blotting, Western | 3 | 2020 | 1147 | 0.070 |
Why?
| Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 13 | 0.070 |
Why?
| Killer Cells, Natural | 2 | 2007 | 380 | 0.070 |
Why?
| Interferon-alpha | 2 | 2006 | 186 | 0.070 |
Why?
| Bone Marrow Cells | 3 | 2016 | 267 | 0.070 |
Why?
| Protein Biosynthesis | 3 | 1992 | 387 | 0.070 |
Why?
| Open Reading Frames | 3 | 1992 | 117 | 0.070 |
Why?
| Sequence Homology, Nucleic Acid | 7 | 1992 | 152 | 0.070 |
Why?
| Molecular Structure | 2 | 2003 | 434 | 0.070 |
Why?
| Poly I-C | 1 | 2006 | 51 | 0.070 |
Why?
| Inflammation Mediators | 1 | 2009 | 477 | 0.070 |
Why?
| Arginine | 2 | 2018 | 238 | 0.070 |
Why?
| Restriction Mapping | 3 | 1998 | 77 | 0.070 |
Why?
| Cell Culture Techniques | 3 | 2009 | 343 | 0.070 |
Why?
| Proteins | 2 | 1982 | 908 | 0.070 |
Why?
| Moths | 3 | 1997 | 35 | 0.070 |
Why?
| Chemotaxis, Leukocyte | 2 | 2003 | 130 | 0.070 |
Why?
| Promoter Regions, Genetic | 4 | 2020 | 1131 | 0.070 |
Why?
| Bone Marrow | 4 | 2009 | 244 | 0.060 |
Why?
| Hyaluronan Receptors | 3 | 2003 | 90 | 0.060 |
Why?
| Mice, Inbred CBA | 7 | 1991 | 49 | 0.060 |
Why?
| Jurkat Cells | 2 | 2009 | 128 | 0.060 |
Why?
| Epithelium | 6 | 1997 | 295 | 0.060 |
Why?
| Nitrophenols | 10 | 2004 | 32 | 0.060 |
Why?
| Lipopolysaccharides | 8 | 2002 | 823 | 0.060 |
Why?
| Proteolysis | 2 | 2018 | 142 | 0.060 |
Why?
| Exons | 2 | 2000 | 302 | 0.060 |
Why?
| Case-Control Studies | 3 | 2020 | 3004 | 0.060 |
Why?
| Organ Culture Techniques | 6 | 1993 | 140 | 0.060 |
Why?
| Oligonucleotides | 2 | 2004 | 137 | 0.060 |
Why?
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.060 |
Why?
| Mice, Inbred A | 6 | 1984 | 45 | 0.060 |
Why?
| Phosphorylation | 4 | 2020 | 1569 | 0.060 |
Why?
| Histocompatibility Antigen H-2D | 4 | 2010 | 21 | 0.060 |
Why?
| Gene Library | 1 | 2004 | 114 | 0.060 |
Why?
| Receptors, Leukotriene B4 | 1 | 2003 | 8 | 0.060 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 174 | 0.060 |
Why?
| Leukotriene B4 | 1 | 2003 | 48 | 0.050 |
Why?
| CD28 Antigens | 2 | 2008 | 47 | 0.050 |
Why?
| Luminescent Proteins | 2 | 2001 | 166 | 0.050 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 154 | 0.050 |
Why?
| Selection, Genetic | 2 | 2019 | 242 | 0.050 |
Why?
| Colorectal Neoplasms | 1 | 2010 | 615 | 0.050 |
Why?
| Amino Acid Substitution | 2 | 2021 | 262 | 0.050 |
Why?
| Myeloid Cells | 1 | 2004 | 126 | 0.050 |
Why?
| Genes, bcl-2 | 1 | 2002 | 20 | 0.050 |
Why?
| Phosphoproteins | 1 | 2005 | 298 | 0.050 |
Why?
| Immunoblotting | 3 | 2008 | 283 | 0.050 |
Why?
| Serum Albumin, Bovine | 6 | 2011 | 61 | 0.050 |
Why?
| HIV Infections | 1 | 2016 | 2469 | 0.050 |
Why?
| Cell Fusion | 4 | 1989 | 50 | 0.050 |
Why?
| Genetic Vectors | 2 | 2001 | 289 | 0.050 |
Why?
| DNA, Viral | 1 | 2004 | 350 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2022 | 124 | 0.050 |
Why?
| Egg Proteins | 1 | 2001 | 19 | 0.050 |
Why?
| Moloney murine leukemia virus | 1 | 2001 | 11 | 0.050 |
Why?
| Genotype | 4 | 2015 | 1760 | 0.050 |
Why?
| Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| Temperature | 2 | 2003 | 565 | 0.050 |
Why?
| Sequence Analysis, DNA | 1 | 2004 | 723 | 0.050 |
Why?
| Transduction, Genetic | 1 | 2001 | 113 | 0.050 |
Why?
| Calcium | 6 | 2004 | 1108 | 0.050 |
Why?
| Receptors, Fc | 2 | 2020 | 45 | 0.050 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 104 | 0.050 |
Why?
| Mitochondria | 2 | 2004 | 747 | 0.050 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 551 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 367 | 0.050 |
Why?
| Hot Temperature | 2 | 2000 | 302 | 0.050 |
Why?
| Dimerization | 2 | 2001 | 176 | 0.050 |
Why?
| Adoptive Transfer | 4 | 2004 | 195 | 0.050 |
Why?
| Borrelia burgdorferi Group | 1 | 2000 | 8 | 0.050 |
Why?
| Perissodactyla | 8 | 1981 | 12 | 0.050 |
Why?
| Immunoglobulin E | 2 | 2019 | 314 | 0.040 |
Why?
| Receptors, Virus | 1 | 2021 | 75 | 0.040 |
Why?
| Interleukin-1 | 5 | 1997 | 966 | 0.040 |
Why?
| Allergy and Immunology | 1 | 2001 | 51 | 0.040 |
Why?
| Netrin-1 | 1 | 2000 | 11 | 0.040 |
Why?
| Biotinylation | 1 | 2000 | 26 | 0.040 |
Why?
| Phorbol Esters | 1 | 2000 | 15 | 0.040 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2001 | 107 | 0.040 |
Why?
| Expressed Sequence Tags | 1 | 2000 | 38 | 0.040 |
Why?
| GTP Phosphohydrolases | 1 | 2000 | 65 | 0.040 |
Why?
| Green Fluorescent Proteins | 3 | 2013 | 371 | 0.040 |
Why?
| Haploidy | 1 | 1980 | 21 | 0.040 |
Why?
| Calorimetry | 1 | 2000 | 60 | 0.040 |
Why?
| Immune Sera | 5 | 1984 | 79 | 0.040 |
Why?
| Diet, High-Fat | 1 | 2021 | 225 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2021 | 129 | 0.040 |
Why?
| Glucose Intolerance | 1 | 2021 | 136 | 0.040 |
Why?
| Circular Dichroism | 1 | 2000 | 135 | 0.040 |
Why?
| NF-kappa B | 1 | 2004 | 641 | 0.040 |
Why?
| B-Cell Activating Factor | 3 | 2006 | 18 | 0.040 |
Why?
| Transcription Factor AP-1 | 1 | 2000 | 80 | 0.040 |
Why?
| Lymphocytic choriomeningitis virus | 2 | 2011 | 20 | 0.040 |
Why?
| Biological Transport | 2 | 1999 | 374 | 0.040 |
Why?
| Protein Conformation, beta-Strand | 1 | 2019 | 15 | 0.040 |
Why?
| Fibroblasts | 4 | 2017 | 838 | 0.040 |
Why?
| Cytoskeletal Proteins | 1 | 2000 | 145 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 98 | 0.040 |
Why?
| Receptors, Complement 3d | 1 | 2020 | 130 | 0.040 |
Why?
| Lipoproteins | 1 | 2000 | 159 | 0.040 |
Why?
| Homozygote | 2 | 1991 | 187 | 0.040 |
Why?
| Horses | 8 | 1981 | 96 | 0.040 |
Why?
| Retroviridae | 2 | 2013 | 90 | 0.040 |
Why?
| Mice, Nude | 3 | 2013 | 630 | 0.040 |
Why?
| Vaccinia | 1 | 1999 | 18 | 0.040 |
Why?
| Computer Simulation | 1 | 2003 | 873 | 0.040 |
Why?
| Immunization, Secondary | 1 | 1999 | 82 | 0.040 |
Why?
| MAP Kinase Kinase Kinases | 1 | 1999 | 68 | 0.040 |
Why?
| Plasmids | 4 | 2001 | 343 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 386 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 184 | 0.040 |
Why?
| Binding Sites, Antibody | 6 | 1991 | 36 | 0.040 |
Why?
| Cell Cycle | 2 | 2020 | 542 | 0.040 |
Why?
| Recombination, Genetic | 4 | 1988 | 176 | 0.040 |
Why?
| Alternative Splicing | 1 | 2000 | 187 | 0.040 |
Why?
| Nucleosomes | 1 | 2020 | 123 | 0.040 |
Why?
| fas Receptor | 4 | 2002 | 91 | 0.040 |
Why?
| Heparin | 1 | 2000 | 224 | 0.040 |
Why?
| Rabbits | 6 | 1984 | 733 | 0.040 |
Why?
| Trinitrobenzenes | 5 | 1982 | 13 | 0.040 |
Why?
| Coculture Techniques | 2 | 2013 | 201 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 923 | 0.040 |
Why?
| Trans-Activators | 2 | 2000 | 367 | 0.040 |
Why?
| Precipitin Tests | 3 | 2001 | 88 | 0.040 |
Why?
| Dogs | 1 | 2019 | 334 | 0.040 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 351 | 0.040 |
Why?
| Young Adult | 3 | 2020 | 10472 | 0.040 |
Why?
| Cartilage | 1 | 2000 | 182 | 0.040 |
Why?
| Asparagine | 1 | 1998 | 29 | 0.040 |
Why?
| Crystallography | 2 | 2007 | 25 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
| Interferon Type I | 1 | 1999 | 128 | 0.040 |
Why?
| Tumor Suppressor Proteins | 1 | 2000 | 282 | 0.040 |
Why?
| Immunoglobulin Fc Fragments | 1 | 1978 | 35 | 0.040 |
Why?
| Receptors, Interferon | 2 | 2013 | 47 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 1999 | 276 | 0.040 |
Why?
| Codon | 1 | 1998 | 86 | 0.040 |
Why?
| Middle Aged | 5 | 2020 | 26738 | 0.040 |
Why?
| Age Factors | 4 | 2017 | 2894 | 0.040 |
Why?
| Lupus Nephritis | 2 | 2006 | 52 | 0.040 |
Why?
| Epithelial Cells | 2 | 2021 | 951 | 0.040 |
Why?
| Societies, Medical | 1 | 2001 | 664 | 0.040 |
Why?
| Cricetinae | 3 | 1994 | 253 | 0.040 |
Why?
| Collagen | 1 | 2000 | 415 | 0.040 |
Why?
| Immunoprecipitation | 2 | 2008 | 151 | 0.040 |
Why?
| Phylogeny | 1 | 2021 | 789 | 0.040 |
Why?
| Caspases | 2 | 2014 | 245 | 0.040 |
Why?
| Immunoglobulin Constant Regions | 3 | 1986 | 6 | 0.040 |
Why?
| Adult | 6 | 2020 | 30554 | 0.040 |
Why?
| Virus Diseases | 2 | 1992 | 195 | 0.030 |
Why?
| Repressor Proteins | 1 | 2000 | 366 | 0.030 |
Why?
| Receptors, IgE | 1 | 1997 | 40 | 0.030 |
Why?
| Germinal Center | 1 | 2017 | 48 | 0.030 |
Why?
| Cats | 1 | 2017 | 193 | 0.030 |
Why?
| Respiratory Hypersensitivity | 1 | 1997 | 60 | 0.030 |
Why?
| Columbidae | 2 | 1994 | 31 | 0.030 |
Why?
| Chromatography, Gel | 3 | 2014 | 122 | 0.030 |
Why?
| High-Throughput Screening Assays | 1 | 2018 | 123 | 0.030 |
Why?
| Emulsions | 1 | 2016 | 42 | 0.030 |
Why?
| Drug Contamination | 1 | 2016 | 52 | 0.030 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 90 | 0.030 |
Why?
| Fetus | 3 | 1993 | 700 | 0.030 |
Why?
| Immunoconjugates | 1 | 1997 | 87 | 0.030 |
Why?
| C-Peptide | 1 | 2016 | 138 | 0.030 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1996 | 61 | 0.030 |
Why?
| Hematopoiesis | 1 | 1997 | 171 | 0.030 |
Why?
| Imidazoles | 1 | 2016 | 208 | 0.030 |
Why?
| Aged | 3 | 2020 | 19074 | 0.030 |
Why?
| Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| Chemokine CCL21 | 1 | 2015 | 13 | 0.030 |
Why?
| Down-Regulation | 3 | 2003 | 594 | 0.030 |
Why?
| Receptors, CCR7 | 1 | 2015 | 24 | 0.030 |
Why?
| Databases, Factual | 1 | 2000 | 1125 | 0.030 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| Static Electricity | 1 | 2015 | 114 | 0.030 |
Why?
| Immunophenotyping | 3 | 2004 | 274 | 0.030 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2014 | 18 | 0.030 |
Why?
| Antibody Diversity | 3 | 1989 | 16 | 0.030 |
Why?
| Recombinant Fusion Proteins | 4 | 2001 | 616 | 0.030 |
Why?
| V(D)J Recombination | 1 | 2014 | 3 | 0.030 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 34 | 0.030 |
Why?
| Cattle | 4 | 2011 | 920 | 0.030 |
Why?
| Biological Transport, Active | 1 | 1994 | 71 | 0.030 |
Why?
| Kidney | 2 | 2017 | 1188 | 0.030 |
Why?
| Hemoglobins | 1 | 1996 | 315 | 0.030 |
Why?
| Chromatography, Ion Exchange | 1 | 2014 | 48 | 0.030 |
Why?
| Early Growth Response Protein 2 | 1 | 2013 | 10 | 0.030 |
Why?
| Culture Techniques | 2 | 1973 | 78 | 0.030 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 5 | 1999 | 31 | 0.030 |
Why?
| Endopeptidases | 1 | 1994 | 71 | 0.030 |
Why?
| Enzyme Activation | 3 | 2001 | 785 | 0.030 |
Why?
| Golgi Apparatus | 1 | 1994 | 89 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2017 | 520 | 0.030 |
Why?
| Receptors, Interleukin-7 | 2 | 2006 | 25 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2017 | 521 | 0.030 |
Why?
| Viral Envelope Proteins | 1 | 1994 | 73 | 0.030 |
Why?
| Adolescent | 4 | 2016 | 17855 | 0.030 |
Why?
| Genetic Carrier Screening | 1 | 1993 | 24 | 0.030 |
Why?
| Forkhead Transcription Factors | 1 | 2014 | 170 | 0.030 |
Why?
| Heparin-binding EGF-like Growth Factor | 1 | 2013 | 11 | 0.030 |
Why?
| Endopeptidase K | 1 | 2013 | 14 | 0.030 |
Why?
| Thymectomy | 5 | 1975 | 15 | 0.030 |
Why?
| Growth Substances | 2 | 1983 | 138 | 0.030 |
Why?
| Interleukin-10 | 1 | 2015 | 299 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2014 | 385 | 0.030 |
Why?
| HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.030 |
Why?
| Adaptive Immunity | 1 | 2014 | 155 | 0.030 |
Why?
| Diphtheria Toxin | 1 | 2013 | 51 | 0.030 |
Why?
| Vomiting | 1 | 1993 | 123 | 0.030 |
Why?
| Minor Histocompatibility Antigens | 1 | 2013 | 41 | 0.030 |
Why?
| Zinc | 1 | 1995 | 260 | 0.030 |
Why?
| Child | 4 | 2016 | 18422 | 0.030 |
Why?
| Genes, MHC Class I | 2 | 2009 | 32 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 314 | 0.030 |
Why?
| Dinoprostone | 2 | 1991 | 184 | 0.030 |
Why?
| DNA Primers | 1 | 2013 | 510 | 0.020 |
Why?
| Microsomes | 1 | 1992 | 24 | 0.020 |
Why?
| DNA Restriction Enzymes | 3 | 1986 | 54 | 0.020 |
Why?
| Proteomics | 1 | 2018 | 836 | 0.020 |
Why?
| Immunoassay | 2 | 1989 | 95 | 0.020 |
Why?
| Cellular Senescence | 1 | 1993 | 152 | 0.020 |
Why?
| Rats | 5 | 2000 | 4958 | 0.020 |
Why?
| Vinblastine | 3 | 1976 | 63 | 0.020 |
Why?
| Methionine | 1 | 1992 | 144 | 0.020 |
Why?
| Nucleocapsid Proteins | 1 | 2011 | 24 | 0.020 |
Why?
| Viral Core Proteins | 1 | 2011 | 20 | 0.020 |
Why?
| Analysis of Variance | 1 | 2014 | 1226 | 0.020 |
Why?
| Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.020 |
Why?
| Receptors, Lymphocyte Homing | 1 | 2011 | 15 | 0.020 |
Why?
| Mice, Inbred NZB | 2 | 2007 | 15 | 0.020 |
Why?
| Cell Adhesion | 3 | 1999 | 432 | 0.020 |
Why?
| Carbohydrates | 1 | 1991 | 55 | 0.020 |
Why?
| Bone Marrow Transplantation | 2 | 1992 | 239 | 0.020 |
Why?
| Rosette Formation | 2 | 1980 | 14 | 0.020 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 54 | 0.020 |
Why?
| Lysine | 1 | 2012 | 242 | 0.020 |
Why?
| Salts | 1 | 2010 | 36 | 0.020 |
Why?
| Minor Histocompatibility Loci | 1 | 1990 | 4 | 0.020 |
Why?
| Mutant Chimeric Proteins | 1 | 2010 | 3 | 0.020 |
Why?
| DNA, Bacterial | 1 | 1992 | 312 | 0.020 |
Why?
| RNA, Double-Stranded | 1 | 2010 | 44 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 72 | 0.020 |
Why?
| Depression, Chemical | 1 | 1990 | 22 | 0.020 |
Why?
| Fibrin | 1 | 2010 | 65 | 0.020 |
Why?
| Immunodominant Epitopes | 1 | 2010 | 25 | 0.020 |
Why?
| HLA-B8 Antigen | 1 | 2009 | 14 | 0.020 |
Why?
| Milk | 1 | 1991 | 124 | 0.020 |
Why?
| HLA-A Antigens | 1 | 2010 | 49 | 0.020 |
Why?
| Epoprostenol | 1 | 1991 | 133 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1993 | 256 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2013 | 444 | 0.020 |
Why?
| Colonic Neoplasms | 1 | 2012 | 215 | 0.020 |
Why?
| Fibrinogen | 1 | 2010 | 154 | 0.020 |
Why?
| Thrombin | 1 | 2010 | 139 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2020 | 6347 | 0.020 |
Why?
| Chromosome Deletion | 4 | 1991 | 95 | 0.020 |
Why?
| Injections, Intraperitoneal | 1 | 2009 | 99 | 0.020 |
Why?
| Antioxidants | 2 | 2003 | 530 | 0.020 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2011 | 194 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2010 | 111 | 0.020 |
Why?
| Immunoglobulin Class Switching | 1 | 2009 | 15 | 0.020 |
Why?
| Tumor Cells, Cultured | 3 | 2000 | 850 | 0.020 |
Why?
| Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.020 |
Why?
| Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.020 |
Why?
| Cell Nucleus | 2 | 1985 | 554 | 0.020 |
Why?
| Disulfides | 3 | 2003 | 90 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 16 | 0.020 |
Why?
| Eosinophils | 2 | 2004 | 278 | 0.020 |
Why?
| Goats | 3 | 1973 | 26 | 0.020 |
Why?
| Caspase 1 | 1 | 2009 | 140 | 0.020 |
Why?
| Cell Adhesion Molecules | 1 | 1990 | 168 | 0.020 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 13 | 0.020 |
Why?
| Phosphorylcholine | 1 | 1988 | 17 | 0.020 |
Why?
| Integrin alpha4 | 1 | 2008 | 6 | 0.020 |
Why?
| Lymphocytic Choriomeningitis | 1 | 2008 | 12 | 0.020 |
Why?
| Transplantation Chimera | 1 | 2008 | 51 | 0.020 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 34 | 0.020 |
Why?
| Shock, Septic | 1 | 1990 | 186 | 0.020 |
Why?
| Genetic Engineering | 1 | 2009 | 80 | 0.020 |
Why?
| Genes, Switch | 1 | 1988 | 5 | 0.020 |
Why?
| Heterozygote | 1 | 1989 | 251 | 0.020 |
Why?
| Glutamic Acid | 1 | 2010 | 211 | 0.020 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2009 | 144 | 0.020 |
Why?
| Antigens, Helminth | 1 | 2008 | 12 | 0.020 |
Why?
| Genes, Regulator | 1 | 1988 | 34 | 0.020 |
Why?
| Influenza Vaccines | 1 | 2013 | 497 | 0.020 |
Why?
| Immunoglobulin Isotypes | 1 | 2008 | 32 | 0.020 |
Why?
| Biosensing Techniques | 1 | 2009 | 100 | 0.020 |
Why?
| RNA-Binding Proteins | 1 | 2011 | 345 | 0.020 |
Why?
| Schistosoma mansoni | 1 | 2008 | 33 | 0.020 |
Why?
| Cross-Priming | 1 | 2008 | 18 | 0.020 |
Why?
| Introns | 1 | 1988 | 227 | 0.020 |
Why?
| Mannose | 1 | 1987 | 21 | 0.020 |
Why?
| Hexosaminidases | 1 | 1987 | 17 | 0.020 |
Why?
| Infection Control | 1 | 2009 | 135 | 0.020 |
Why?
| Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| Yersinia enterocolitica | 1 | 2007 | 6 | 0.020 |
Why?
| Oligosaccharides | 1 | 1987 | 46 | 0.020 |
Why?
| Genetic Variation | 2 | 1990 | 870 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2007 | 57 | 0.020 |
Why?
| Leukemia P388 | 2 | 1984 | 7 | 0.020 |
Why?
| Fluoresceins | 2 | 2004 | 46 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 2 | 2003 | 1842 | 0.020 |
Why?
| Weight Loss | 1 | 1992 | 642 | 0.020 |
Why?
| Nucleic Acid Conformation | 1 | 2010 | 669 | 0.020 |
Why?
| Hypersensitivity, Delayed | 3 | 1978 | 27 | 0.020 |
Why?
| Pepsin A | 1 | 1986 | 18 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 47 | 0.020 |
Why?
| Lymphoma | 5 | 1985 | 177 | 0.020 |
Why?
| Immunologic Techniques | 2 | 1983 | 39 | 0.020 |
Why?
| Antibodies, Antinuclear | 1 | 2006 | 58 | 0.020 |
Why?
| Oligonucleotides, Antisense | 2 | 2000 | 100 | 0.020 |
Why?
| Health | 1 | 2007 | 74 | 0.020 |
Why?
| Half-Life | 2 | 1977 | 141 | 0.020 |
Why?
| Proteinuria | 1 | 2006 | 77 | 0.020 |
Why?
| Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| Transgenes | 2 | 1997 | 170 | 0.020 |
Why?
| Leukopoiesis | 1 | 2006 | 10 | 0.020 |
Why?
| Peptide Hydrolases | 1 | 2006 | 104 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 2006 | 100 | 0.020 |
Why?
| Body Weight | 1 | 1990 | 869 | 0.020 |
Why?
| Guinea Pigs | 2 | 1977 | 136 | 0.020 |
Why?
| Immunoenzyme Techniques | 1 | 1985 | 192 | 0.020 |
Why?
| Drug Synergism | 2 | 1983 | 317 | 0.020 |
Why?
| United States | 1 | 2001 | 12186 | 0.020 |
Why?
| Prostaglandins E | 1 | 1985 | 44 | 0.020 |
Why?
| Cytoplasm | 1 | 1985 | 255 | 0.020 |
Why?
| Succinimides | 1 | 2004 | 15 | 0.020 |
Why?
| Immunoglobulin Light Chains | 1 | 1984 | 36 | 0.010 |
Why?
| Protein Denaturation | 1 | 1984 | 68 | 0.010 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 6 | 0.010 |
Why?
| Sex Factors | 1 | 2010 | 1715 | 0.010 |
Why?
| Freund's Adjuvant | 1 | 2004 | 17 | 0.010 |
Why?
| Albumins | 1 | 1984 | 89 | 0.010 |
Why?
| Interphase | 2 | 2000 | 32 | 0.010 |
Why?
| DNA, Complementary | 1 | 2004 | 256 | 0.010 |
Why?
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.010 |
Why?
| Immunoglobulins | 1 | 1984 | 143 | 0.010 |
Why?
| Genetic Markers | 1 | 1985 | 320 | 0.010 |
Why?
| Antigens, Differentiation | 2 | 1997 | 79 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 1983 | 33 | 0.010 |
Why?
| Leukemia, Experimental | 1 | 1983 | 27 | 0.010 |
Why?
| Macrophage-Activating Factors | 1 | 1983 | 4 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 140 | 0.010 |
Why?
| Incidence | 1 | 2010 | 2313 | 0.010 |
Why?
| Catalase | 1 | 2003 | 118 | 0.010 |
Why?
| Hemagglutination Tests | 2 | 1973 | 7 | 0.010 |
Why?
| Lung Diseases | 1 | 2010 | 701 | 0.010 |
Why?
| Receptors, CCR5 | 1 | 2003 | 54 | 0.010 |
Why?
| B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| Nucleic Acid Hybridization | 2 | 1999 | 187 | 0.010 |
Why?
| Prognosis | 1 | 1991 | 3330 | 0.010 |
Why?
| Birds | 1 | 1983 | 76 | 0.010 |
Why?
| Fas Ligand Protein | 1 | 2003 | 57 | 0.010 |
Why?
| Karyotyping | 1 | 1983 | 102 | 0.010 |
Why?
| Neuropeptides | 1 | 2003 | 65 | 0.010 |
Why?
| Graft Rejection | 1 | 1986 | 513 | 0.010 |
Why?
| Lymphocyte Culture Test, Mixed | 3 | 1990 | 41 | 0.010 |
Why?
| Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| Fetal Blood | 1 | 1983 | 270 | 0.010 |
Why?
| Bacterial Proteins | 1 | 2007 | 736 | 0.010 |
Why?
| Sex Chromosome Aberrations | 1 | 1981 | 51 | 0.010 |
Why?
| Virus Assembly | 1 | 2002 | 67 | 0.010 |
Why?
| Vaccinia virus | 1 | 2001 | 27 | 0.010 |
Why?
| Phosphotyrosine | 1 | 2001 | 33 | 0.010 |
Why?
| CD79 Antigens | 1 | 2001 | 16 | 0.010 |
Why?
| Growth Inhibitors | 1 | 2001 | 43 | 0.010 |
Why?
| Genes, Reporter | 1 | 2001 | 257 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 268 | 0.010 |
Why?
| Myoglobin | 1 | 2000 | 14 | 0.010 |
Why?
| Child, Preschool | 2 | 1993 | 9119 | 0.010 |
Why?
| Sequence Analysis | 1 | 2000 | 35 | 0.010 |
Why?
| Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| Up-Regulation | 1 | 2003 | 808 | 0.010 |
Why?
| Biopolymers | 1 | 2000 | 26 | 0.010 |
Why?
| Lymphocyte Subsets | 1 | 2000 | 79 | 0.010 |
Why?
| Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.010 |
Why?
| Lyme Disease | 1 | 2000 | 32 | 0.010 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 11 | 0.010 |
Why?
| Staining and Labeling | 2 | 1980 | 134 | 0.010 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2000 | 59 | 0.010 |
Why?
| HLA-DRB1 Chains | 1 | 2000 | 98 | 0.010 |
Why?
| Bacterial Vaccines | 1 | 2000 | 61 | 0.010 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 17 | 0.010 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| Receptors, Interleukin-6 | 1 | 2000 | 34 | 0.010 |
Why?
| In Situ Hybridization | 1 | 2000 | 292 | 0.010 |
Why?
| Cell Lineage | 1 | 2001 | 309 | 0.010 |
Why?
| Septins | 1 | 2000 | 40 | 0.010 |
Why?
| GTP-Binding Proteins | 1 | 2000 | 139 | 0.010 |
Why?
| STAT1 Transcription Factor | 1 | 2000 | 64 | 0.010 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| Indicators and Reagents | 1 | 2000 | 99 | 0.010 |
Why?
| Genes, Dominant | 1 | 1999 | 94 | 0.010 |
Why?
| Lymphocyte Transfusion | 1 | 1999 | 19 | 0.010 |
Why?
| Leukemia L1210 | 1 | 1999 | 7 | 0.010 |
Why?
| Multigene Family | 2 | 1991 | 190 | 0.010 |
Why?
| Lymphopenia | 1 | 1999 | 49 | 0.010 |
Why?
| Tissue Distribution | 2 | 1993 | 286 | 0.010 |
Why?
| Androstadienes | 1 | 1999 | 97 | 0.010 |
Why?
| Protein Isoforms | 1 | 2000 | 338 | 0.010 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 144 | 0.010 |
Why?
| Free Radical Scavengers | 1 | 1999 | 78 | 0.010 |
Why?
| Manganese | 1 | 1999 | 55 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 146 | 0.010 |
Why?
| Cholic Acids | 1 | 1998 | 17 | 0.010 |
Why?
| Nuclear Proteins | 1 | 2003 | 591 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 164 | 0.010 |
Why?
| Detergents | 1 | 1998 | 41 | 0.010 |
Why?
| Metalloporphyrins | 1 | 1999 | 103 | 0.010 |
Why?
| Membrane Potentials | 1 | 1999 | 248 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 260 | 0.010 |
Why?
| Absorption | 2 | 1975 | 52 | 0.010 |
Why?
| STAT3 Transcription Factor | 1 | 2000 | 173 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 1999 | 278 | 0.010 |
Why?
| Polysaccharides, Bacterial | 2 | 1975 | 66 | 0.010 |
Why?
| Infant | 1 | 1991 | 7964 | 0.010 |
Why?
| Histocompatibility | 1 | 1977 | 26 | 0.010 |
Why?
| Endocytosis | 1 | 1998 | 148 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1999 | 396 | 0.010 |
Why?
| Isoantigens | 1 | 1977 | 17 | 0.010 |
Why?
| Protein-Tyrosine Kinases | 1 | 2001 | 395 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 329 | 0.010 |
Why?
| STAT6 Transcription Factor | 1 | 1997 | 22 | 0.010 |
Why?
| Abatacept | 1 | 1997 | 40 | 0.010 |
Why?
| Hybridization, Genetic | 1 | 1978 | 78 | 0.010 |
Why?
| Autoanalysis | 1 | 1977 | 6 | 0.010 |
Why?
| Trypan Blue | 1 | 1977 | 4 | 0.010 |
Why?
| Interleukins | 1 | 1999 | 236 | 0.010 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 147 | 0.010 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 1977 | 43 | 0.010 |
Why?
| Warfarin | 1 | 1978 | 135 | 0.010 |
Why?
| CTLA-4 Antigen | 1 | 1997 | 76 | 0.010 |
Why?
| Whole-Body Irradiation | 1 | 1997 | 73 | 0.010 |
Why?
| Genetic Complementation Test | 2 | 1986 | 62 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 750 | 0.010 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 84 | 0.010 |
Why?
| Immunity, Mucosal | 1 | 1997 | 84 | 0.010 |
Why?
| Sequence Homology | 1 | 1995 | 39 | 0.010 |
Why?
| Radiation Effects | 1 | 1975 | 4 | 0.010 |
Why?
| Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| Surface Properties | 1 | 1976 | 387 | 0.010 |
Why?
| Trachea | 1 | 1997 | 224 | 0.010 |
Why?
| Skin Tests | 1 | 1975 | 116 | 0.010 |
Why?
| Complement System Proteins | 2 | 1974 | 283 | 0.010 |
Why?
| Methods | 1 | 1974 | 58 | 0.010 |
Why?
| CD4-CD8 Ratio | 1 | 1993 | 19 | 0.010 |
Why?
| Transferrin | 1 | 1993 | 39 | 0.010 |
Why?
| Umbilical Cord | 1 | 1994 | 80 | 0.010 |
Why?
| Hindlimb | 1 | 1974 | 130 | 0.010 |
Why?
| Animals, Newborn | 2 | 1988 | 778 | 0.010 |
Why?
| Transplantation Immunology | 1 | 1993 | 30 | 0.010 |
Why?
| Cell Transplantation | 1 | 1993 | 36 | 0.010 |
Why?
| Immunoglobulin M | 1 | 1975 | 246 | 0.010 |
Why?
| Viral Plaque Assay | 1 | 1973 | 24 | 0.010 |
Why?
| Bufo marinus | 1 | 1973 | 4 | 0.010 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 1983 | 53 | 0.010 |
Why?
| Macaca mulatta | 1 | 1993 | 131 | 0.010 |
Why?
| Blotting, Southern | 1 | 1993 | 68 | 0.010 |
Why?
| Pedigree | 1 | 1994 | 460 | 0.010 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.010 |
Why?
| Liver | 2 | 1992 | 1637 | 0.010 |
Why?
| DNA Methylation | 1 | 1996 | 496 | 0.010 |
Why?
| Embryonic and Fetal Development | 1 | 1992 | 94 | 0.010 |
Why?
| Disease | 1 | 1993 | 85 | 0.010 |
Why?
| Models, Structural | 1 | 1991 | 37 | 0.010 |
Why?
| Immunotherapy, Adoptive | 1 | 1993 | 184 | 0.010 |
Why?
| Ionomycin | 1 | 1991 | 24 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1992 | 138 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1991 | 153 | 0.010 |
Why?
| Erythrocyte Transfusion | 1 | 1973 | 189 | 0.010 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| Calcimycin | 1 | 1991 | 47 | 0.010 |
Why?
| Blotting, Northern | 1 | 1991 | 193 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1997 | 847 | 0.010 |
Why?
| Arthritis | 1 | 1991 | 109 | 0.010 |
Why?
| RNA Splicing | 1 | 1991 | 245 | 0.010 |
Why?
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.010 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 5 | 0.010 |
Why?
| Thymidine | 1 | 1970 | 58 | 0.010 |
Why?
| Oligonucleotide Probes | 1 | 1990 | 54 | 0.010 |
Why?
| Amidohydrolases | 1 | 1990 | 28 | 0.010 |
Why?
| Cytosine | 1 | 1970 | 44 | 0.010 |
Why?
| Carbon Isotopes | 1 | 1970 | 111 | 0.010 |
Why?
| Gestational Age | 1 | 1992 | 760 | 0.010 |
Why?
| Cricetulus | 1 | 1989 | 97 | 0.010 |
Why?
| Reference Values | 1 | 1990 | 743 | 0.000 |
Why?
| Extracellular Space | 1 | 1989 | 116 | 0.000 |
Why?
| Cross-Linking Reagents | 1 | 1989 | 181 | 0.000 |
Why?
| Microspheres | 1 | 1988 | 123 | 0.000 |
Why?
| Leukocyte Count | 1 | 1988 | 293 | 0.000 |
Why?
| Bacteriophage lambda | 1 | 1988 | 81 | 0.000 |
Why?
| Adrenergic beta-Antagonists | 1 | 1970 | 287 | 0.000 |
Why?
| Enhancer Elements, Genetic | 1 | 1988 | 151 | 0.000 |
Why?
| Liposomes | 1 | 1988 | 146 | 0.000 |
Why?
| Models, Biological | 1 | 1993 | 1621 | 0.000 |
Why?
| Staphylococcal Infections | 1 | 1990 | 340 | 0.000 |
Why?
| Glass | 1 | 1986 | 42 | 0.000 |
Why?
| Liver Transplantation | 1 | 1992 | 707 | 0.000 |
Why?
| Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| Mast-Cell Sarcoma | 1 | 1985 | 4 | 0.000 |
Why?
| Transformation, Genetic | 1 | 1985 | 15 | 0.000 |
Why?
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1984 | 1 | 0.000 |
Why?
| Mesylates | 1 | 1984 | 8 | 0.000 |
Why?
| Acetylglucosaminidase | 1 | 1984 | 5 | 0.000 |
Why?
| Sezary Syndrome | 1 | 1984 | 43 | 0.000 |
Why?
| Bacteria | 1 | 1991 | 725 | 0.000 |
Why?
| Membranes, Artificial | 1 | 1984 | 65 | 0.000 |
Why?
| Rats, Inbred Strains | 1 | 1984 | 362 | 0.000 |
Why?
| Thymus Neoplasms | 1 | 1984 | 21 | 0.000 |
Why?
| Isoelectric Point | 1 | 1984 | 22 | 0.000 |
Why?
| Longitudinal Studies | 1 | 1990 | 2387 | 0.000 |
Why?
| Tomography, X-Ray Computed | 1 | 1993 | 2286 | 0.000 |
Why?
| Fixatives | 1 | 1983 | 15 | 0.000 |
Why?
| Cell-Free System | 1 | 1983 | 47 | 0.000 |
Why?
| Glutaral | 1 | 1983 | 14 | 0.000 |
Why?
| Receptors, Antigen | 1 | 1983 | 10 | 0.000 |
Why?
| Chemical Precipitation | 1 | 1983 | 37 | 0.000 |
Why?
| Magnetic Resonance Imaging | 1 | 1993 | 3053 | 0.000 |
Why?
| X Chromosome | 1 | 1981 | 47 | 0.000 |
Why?
| Brain | 1 | 1993 | 2371 | 0.000 |
Why?
| Pulmonary Alveoli | 1 | 1983 | 373 | 0.000 |
Why?
| Pregnancy | 1 | 1992 | 5520 | 0.000 |
Why?
| Polymers | 1 | 1983 | 448 | 0.000 |
Why?
| Sarcoma, Experimental | 1 | 1974 | 5 | 0.000 |
Why?
| Immunoglobulin Fragments | 1 | 1974 | 15 | 0.000 |
Why?
|
|
Kappler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|